Stay updated with breaking news from Andrean Riner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Black patients were also more likely to be ineligible because of renal dysfunction, recent coronary stenting, and uncontrolled diabetes mellitus.
Traditional eligibility criteria differentially exclude Black patients from participating in clinical trials for pancreatic ductal adenocarcinoma.
THURSDAY, April 7, 2022 (HealthDay News) — Traditional eligibility criteria differentially exclude Black patients from participating in clinical trials for pancreatic ductal adenocarcinoma (PDAC), according to a study published online March 22 in the Journal of Clinical Oncology. Andrea N. Riner, M.D., M.P.H., from University of Florida in Gainesville, and colleagues assessed the impact of […]
Difference in outcomes of common operations seen in population-based study
A simulated pancreatic cancer clinical trial screening process showed that Black patients were significantly more likely than white patients to be excluded from clinical trials for a wide range of eligibility criteria, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held October 6-8, 2021.